Latest Breaking News On - Cereno scientific inc - Page 1 : comparemela.com

Cereno Scientific is granted Expanded Access by the FDA to drug candidate CS1 for rare disease pulmonary arterial hypertension

Cereno Scientific , a company developing innovative treatments for common and rare cardiovascular disease, today announced that the company has been granted approval by the FDA for Expanded Access,.

United statesVastra gotalands lanKendall squareRaymond benzaCereno expanded access programIr communicationsAccess programClinical steering committeeCereno scientific incMount sinai health systemUniversity of michiganCereno scientificNasdaq first northExpanded accessExpanded access programExtended access program

Cereno Scientific confirms new clinic activated in the Phase II study of drug candidate CS1 in rare disease PAH

Cereno Scientific , a company developing innovative treatments for common and rare cardiovascular disease, today announced that a new clinic has been activated in the ongoing Phase II study of CS1 in.

United statesVastra gotalands lanKendall squareIr communicationsCereno scientific incAbbott incUniversity of michiganCereno scientificNasdaq first north

Cereno Scientific: Nomination committee appointed ahead of annual general meeting 2024 -Today at 09:11 am

Cereno Scientific , a company developing innovative treatments for common and rare cardiovascular disease, today announced that the representatives of the nomination committee have been appointed.

Vastra gotalands lanUnited statesKendall squareEva jagenheimAstrazeneca bioventurehubSverker jernNiklas berghCihan punarUniversity of michiganCereno scientific incCereno scientificNasdaq first north

Cereno Scientific reports an investigator-initiated patient case study from the ongoing Phase II study of CS1 in PAH

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced data received from a patient case study initiated by an investigator on the first patient having co.

United statesVastra gotalands lanJonas fogelbergKendall squareUniversity of michiganClinical steering committeeAbbott incCereno scientific incCereno scientificNasdaq first north

Cereno Scientific publishes an additional document in conjunction with admission to trading on Nasdaq First North Growth Market

Cereno Scientific publishes an additional document in conjunction with admission to trading on Nasdaq First North Growth Market
privataaffarer.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from privataaffarer.se Daily Mail and Mail on Sunday newspapers.

United statesVastra gotalands lanJonas fogelbergKendall squareUniversity of michiganCompany certified adviserCereno scientific incCereno scientificNasdaq first northNasdaq firstSwedish spotlight stock market